ICU Medical, Inc. (NASDAQ:ICUI) CFO Scott E. Lamb sold 23,772 shares of the stock in a transaction dated Tuesday, July 11th. The stock was sold at an average price of $170.02, for a total transaction of $4,041,715.44. Following the transaction, the chief financial officer now owns 9,050 shares of the company’s stock, valued at $1,538,681. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
Shares of ICU Medical, Inc. (NASDAQ:ICUI) traded down 0.61% during midday trading on Tuesday, reaching $171.55. 116,162 shares of the company traded hands. ICU Medical, Inc. has a 12-month low of $116.22 and a 12-month high of $176.50. The company has a 50-day moving average of $172.15 and a 200 day moving average of $157.46. The firm has a market capitalization of $3.40 billion, a PE ratio of 30.49 and a beta of 0.37.
ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Wednesday, May 10th. The medical instruments supplier reported $1.68 EPS for the quarter, topping the Zacks’ consensus estimate of $0.45 by $1.23. ICU Medical had a net margin of 18.76% and a return on equity of 9.63%. The firm had revenue of $247.74 million for the quarter, compared to analyst estimates of $237.12 million. During the same quarter in the prior year, the firm earned $1.26 EPS. The business’s revenue for the quarter was up 175.7% compared to the same quarter last year. On average, equities analysts forecast that ICU Medical, Inc. will post $4.14 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: This story was first reported by Markets Daily and is the sole property of of Markets Daily. If you are reading this story on another site, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The original version of this story can be viewed at https://www.themarketsdaily.com/2017/08/08/icu-medical-inc-icui-cfo-sells-4041715-44-in-stock-updated-updated-updated.html.
Several institutional investors have recently added to or reduced their stakes in the stock. Creative Planning raised its position in ICU Medical by 315.6% in the first quarter. Creative Planning now owns 665 shares of the medical instruments supplier’s stock valued at $102,000 after buying an additional 505 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in ICU Medical by 10.3% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 707 shares of the medical instruments supplier’s stock valued at $122,000 after buying an additional 66 shares in the last quarter. Victory Capital Management Inc. raised its position in ICU Medical by 17.6% in the second quarter. Victory Capital Management Inc. now owns 1,050 shares of the medical instruments supplier’s stock valued at $181,000 after buying an additional 157 shares in the last quarter. Ameritas Investment Partners Inc. acquired a new position in ICU Medical during the first quarter valued at approximately $194,000. Finally, Parametrica Management Ltd acquired a new position in ICU Medical during the second quarter valued at approximately $213,000. 77.85% of the stock is currently owned by institutional investors.
ICUI has been the subject of a number of recent research reports. Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $193.00 price objective for the company in a research note on Thursday, July 20th. BidaskClub upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Saturday, June 17th. Sidoti downgraded shares of ICU Medical from a “buy” rating to a “neutral” rating in a research note on Tuesday, June 20th. Finally, Roth Capital downgraded shares of ICU Medical from a “buy” rating to a “neutral” rating in a research note on Thursday, May 11th. They noted that the move was a valuation call. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. ICU Medical has an average rating of “Hold” and a consensus target price of $156.00.
About ICU Medical
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.